Skip to content

Kai Rothkamm

  • PhD
  • Professor
  • University Medical Center Hamburg-Eppendorf
  • 30h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 5032CitationsNumber of citations received by Kai's publications. Updated daily.

Recent publications

  • BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy

    • Oing C
    • Tennstedt P
    • Simon R
    • et al.
    Get full text
  • Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer

    • Mansour W
    • Tennstedt P
    • Volquardsen J
    • et al.
    Get full text

Professional experience


University Medical Center Hamburg-Eppendorf

February 2015 - Present

Senior Scientific Group Leader

Public Health England, Centre for Radiation Chemical and Environmental Hazards

March 2008 - January 2015(7 years)

Cancer Research UK Junior Group Leader

Gray Institute for Radiation Oncology and Biology

February 2006 - March 2008(2 years)

Senior Scientist

Gray Cancer Institute

September 2003 - January 2006(2 years)

Post doc

Saarland Unversity Medical Faculty

August 1999 - August 2003(4 years)

Co-authors (359)